Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
PC 360
Article
Property Casualty 360: The opioid epidemic in workers' comp
Employers can use these five strategies to manage opioid issues in their organizations and help injured workers heal.
PC 360
Article
Property Casualty 360: The opioid epidemic in workers' comp
Employers can use these five strategies to manage opioid issues in their organizations and help injured workers heal.
PDF
Article
In a Data-Filled World: Stories That Rely Solely on Numbers Don’t Add Up
Workers' Comp
Article
In a Data-filled World, Stories That Rely Solely on Numbers Don’t Add Up
Storytelling sometimes seems to be a lost art.
WorkCompWire
Article
Mark Pew on “The Intersection of Medicine and Disability” from NWCDC
At the 2017 #NWCDConf in Las Vegas on December 7, Dr.
Workers' Comp
Article
CLM Magazine: Clinical and Legal Advocacy in a WCMSA
Strategic approaches for cost minimization in Medicare Set-Asides